Our research results and past published evidence uniformly indicate that acyl-carnitine profiles may be a useful indicator of metabolic changes in schizophrenia, additionally acyl-carnitine supplementation therapies may have accompanying positive potential in the treatment of schizophrenia

Why Doctors Dont Prescribe Rybelsus for Weight Loss: Most weight loss physicians dont recommend Rybelsus for weight loss because: Much less effective than injectable options Strict dosing requirements reduce real-world effectiveness Higher cost for significantly lower results Not covered by insurance for weight loss indication Injectable options produce better outcomes with once-weekly dosing versus daily tablets Who Uses Rybelsus: Primarily patients with type 2 diabetes who: Have severe needle phobia preventing injectable use Want to try a GLP-1 but refuse injections Are starting GLP-1 therapy and testing tolerance before committing to injections Have mild diabetes not requiring aggressive management Cost Comparison: List Price: Approximately $900-$1,000 per month With Insurance: $25-$300 depending on coverage (usually for diabetes, not weight loss) Without Insurance: Full price unless using manufacturer coupon For comparison, compounded injectable semaglutide costs $199/month and produces far superior weight loss results

Simply Wellness Guarantee 100% Satisfaction or Your Money Back We believe in the effectiveness of our weight loss treatments and the exceptional care provided by our team
This is individualizing dosing under close medical supervision to address specific clinical situations
On April 30, 2026, the FDA proposed to formally exclude Semaglutide, Tirzepatide, and Liraglutide from the 503B Bulks List, citing no clinical need for outsourcing facilities to compound these drugs from bulk substances